HiRO – Global CRO: Paving the Way for Biotech Innovations
Innovation is what propels the biotech industry forward, leading to an impressive array of ground-breaking products. Biotech companies are at the forefront of these scientific breakthroughs, utilizing their specialized knowledge to transform medicine and healthcare.
However, the journey from conceptualization to market is not without its complexities and challenges, particularly for newer or smaller entities that may lack the extensive resources required to navigate the intricacies of clinical trials.
“With 18 years in the CRO industry, along with first-hand involvement in start-ups, and venture capital, I have seen enough to recognize the challenges facing biotechs to bring new innovations to market. We established HiRO – Harvest Integrated Research Organization to better serve the needs of biotech and accelerate clinical research.” – Karen Chu, CEO and Founder of HiRO
HiRO is now revolutionizing the CRO landscape and driving biotech innovation. Explore In this article, the complexities of the biotech industry and how HiRO’s approach drives better solutions and efficiencies.
Supporting biotech companies
The biotechnology sector is driven by innovation, particularly evident in the stream of ground-breaking products making their way into clinical research. Biotech companies often lead the charge in scientific advancement, harnessing their expertise to push the boundaries of medicine and healthcare. However, these organizations also face significant hurdles, especially when it comes to resources and the intricate process of clinical research.
To successfully conduct a clinical trial, a biotech company needs a robust team of professionals, including physicians, statisticians, and regulatory experts, among others. This also requires an in-depth understanding of various functions, from clinical development pathways to patient enrolment strategies. However, biotech companies, especially new or smaller ones, often lack the comprehensive resources necessary to navigate these complexities.
This is where specialized support becomes invaluable. CROs like HiRO have emerged as essential partners for biotech companies. They provide a spectrum of services and the much-needed support to shepherd these companies through the demanding world of clinical research. By offering resources in flexible ways, including staffing, complete project outsourcing, or even consultation, these CROs ensure that innovative healthcare products can overcome the challenging journey from the lab to the market.
HiRO’s approach
HiRO recognizes the challenges biotech startups face, especially those with limited resources. The multitude of decisions to be made can make reaching market a slower and more complex process. On top of that, unfamiliar global frameworks can result in costly delays and place even more strain on decision making.
HiRO operates beyond the traditional CRO model by seeking to integrate more closely with client teams and engage earlier in the clinical development pathway. This early involvement allows the CRO to help design effective clinical development programs, advising on strategic decisions such as selecting countries for trials, understanding local regulatory landscapes and medical practices, and identifying suitable partners and vendors for cross-border research to accelerate timelines.
“We assist our clients to determine the right global development pathway for each unique situation. Our networks provide biotechs access to identify the resourcing they require, the right vendors and subcontractors and even navigating the intricate pathways of fundraising. Our consultancy services are comprehensive, offering guidance from the preclinical stage onwards and covering various operational facets of clinical trial management.” Wendy Mach, HiRO Vice President, Strategy & Partnering Office
Navigating global clinical research challenges
Clinical research requires diversity and a global patient base. However, this global approach comes with its own set of challenges, including differing regulatory frameworks, medical practices, and cultural nuances, all of which can lead to unforeseen costs and delays. Here, HiRO positions itself as an indispensable guide, helping its clients foresee and navigate potential potholes in their journey.
The strength of our approach lies in its experienced management team, which boasts extensive careers in clinical research, biotech, pharma, and both global and smaller CROs. This diverse experience pool allows us to bridge the local-global divide effectively, offering clients a clear communication hierarchy and direct access to top management — a refreshing change from the impersonality often associated with larger CROs.
Moreover, HiRO understands and addresses various pain points for biotech companies, including the need for flexibility in rapid problem-solving, budget constraints, and patient enrolment strategies.
HiRO – we understand biotech
Leveraging the HiRO team’s unique understanding of biotech HiRO is distinctively positioned to guide biotech innovations from lab to market with strategic support.
With our comprehensive support, adaptable services, and global expertise, we are not just facilitators but active enablers of the next wave of medical breakthroughs. Our role in the journey of a healthcare product — from lab to market — is a testament to the collaborative spirit that drives scientific advancement.
